Sandoz announces agreement to acquire CIMERLI® business

Sandoz announces agreement to acquire CIMERLI® business from Coherus, strengthening position in US market

GlobeNewswire

January 22, 2024



Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Basel, January 22, 2024 – Sandoz, the global leader in generic and biosimilar medicines, has signed an agreement to acquire...

Related Keywords

Switzerland , United States , Swiss , American , Joerge Allgaeuer , Coherus Biosciences , Karenm King , Keren Haruvi , Choroidal Neovascularization , Chris Lewis , Coherus Biosciences Inc , Genentech United States Inc , American Academy Of Ophthalmology , Swiss Exchange Listing , Exchange Listing , President Sandoz North America , Age Related Macular Degeneration , Edema Following Retinal Vein Occlusion , Macular Edema , Safety Information , Full Prescribing Information , Genentech United States , Full Prescribing , Media Release , Calcium Sandoz , Media Relations ,